Objective: Determine if CVL-354 is a short-acting (<24 hours) kappa opioid receptor antagonist.
Objective: Determine if CVL-354 is a short-acting (<24 hours) kappa opioid receptor antagonist.
You are now leaving cerevel.com, a website provided by Cerevel Therapeutics. The content displayed on external websites is not controlled by Cerevel, and Cerevel assumes no responsibility for the information or statements on external websites.